At the Forefront of Immunology: WSA Interviews Immune Pharma and TapImmune
Wall Street Analyzer’s CEO Interview Series […]
Wall Street Analyzer’s CEO Interview Series […]
Interview with CEO Dr. James Bailey […]
GlobalSCAPE, Inc (NYSE:GSB) CEO: James Bindseil THIS INTERVIEW HAS EXPIRED
Interview with CEO Bill Long […]
Interview with CEO Ben Butcher […]
Interview with Chairman and CTO Raja Tuli […]
Interview with Jeff Bacha, CEO […]
Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing.
Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com